» Articles » PMID: 38524671

Differential Roles of Normal and Lung Cancer-associated Fibroblasts in Microvascular Network Formation

Overview
Journal APL Bioeng
Date 2024 Mar 25
PMID 38524671
Authors
Affiliations
Soon will be listed here.
Abstract

Perfusable microvascular networks offer promising three-dimensional models to study normal and compromised vascular tissues as well as phenomena such as cancer cell metastasis. Engineering of these microvascular networks generally involves the use of endothelial cells stabilized by fibroblasts to generate robust and stable vasculature. However, fibroblasts are highly heterogenous and may contribute variably to the microvascular structure. Here, we study the effect of normal and cancer-associated lung fibroblasts on the formation and function of perfusable microvascular networks. We examine the influence of cancer-associated fibroblasts on microvascular networks when cultured in direct (juxtacrine) and indirect (paracrine) contacts with endothelial cells, discovering a generative inhibition of microvasculature in juxtacrine co-cultures and a functional inhibition in paracrine co-cultures. Furthermore, we probed the secreted factors differential between cancer-associated fibroblasts and normal human lung fibroblasts, identifying several cytokines putatively influencing the resulting microvasculature morphology and functionality. These findings suggest the potential contribution of cancer-associated fibroblasts in aberrant microvasculature associated with tumors and the plausible application of such platforms in identifying new therapeutic targets and/or agents that can prevent formation of aberrant vascular structures.

References
1.
Pill K, Melke J, Muhleder S, Pultar M, Rohringer S, Priglinger E . Microvascular Networks From Endothelial Cells and Mesenchymal Stromal Cells From Adipose Tissue and Bone Marrow: A Comparison. Front Bioeng Biotechnol. 2018; 6:156. PMC: 6209673. DOI: 10.3389/fbioe.2018.00156. View

2.
Fang D, Sun L, Lin S, Zhou L, Su N, Yuan S . Vinorelbine inhibits angiogenesis and 95D migration via reducing hypoxic fibroblast stromal cell-derived factor 1 secretion. Exp Biol Med (Maywood). 2012; 237(9):1045-55. DOI: 10.1258/ebm.2012.012037. View

3.
Jang I, Beningo K . Integrins, CAFs and Mechanical Forces in the Progression of Cancer. Cancers (Basel). 2019; 11(5). PMC: 6562616. DOI: 10.3390/cancers11050721. View

4.
Uwamori H, Ono Y, Yamashita T, Arai K, Sudo R . Comparison of organ-specific endothelial cells in terms of microvascular formation and endothelial barrier functions. Microvasc Res. 2018; 122:60-70. PMC: 6294313. DOI: 10.1016/j.mvr.2018.11.007. View

5.
Huang B, Huang M, Li Q . Cancer-Associated Fibroblasts Promote Angiogenesis of Hepatocellular Carcinoma by -Mediated Pathway. Technol Cancer Res Treat. 2019; 18:1533033819879905. PMC: 6876164. DOI: 10.1177/1533033819879905. View